EORTC is an academic, independent, non-profit organization under Belgian law, with no direct government subsidy. Our revenue comes from grants from institutional, corporate and private donors and fees charged for studies conducted with partners or services to the oncology community that enables us to fulfil our mission and vision.
Clinical studies evaluating new drugs for potential registration, or testing therapeutic agents, are conducted in partnership with commercial organizations. This funding is subject to EORTC’s strict principles of independence. The pie chart shows the total income of EORTC and its source, the figures provided refer to the book-year 2022: